NCT01471340View on ClinicalTrials.gov

A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241)

PHASE4CompletedINTERVENTIONAL

Enrollment

11,744

Participants

Timeline

Start Date

January 9, 2012

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions

Asthma

Interventions

DRUG

Mometasone Furoate/Formoterol MDI 100/5 mcg

two inhalations BID

DRUG

Mometasone Furoate/Formoterol MDI 200/5 mcg

two inhalations BID

DRUG

Mometasone Furoate MDI 100 mcg

two inhalations BID

DRUG

Mometasone Furoate MDI 200 mcg

two inhalations BID

DRUG

Albuterol 90 mcg /salbutamol 100 mcg HFA MDI

use as needed for asthma symptoms

DRUG

Prednisone/prednisolone

Oral prednisone/prednisolone used only as an emergency rescue medication at the discretion of the investigator

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT01471340 - A Serious Asthma Outcome Study With Mometasone Furoate/Formoterol Versus Mometasone Furoate in Asthmatics 12 Years and Over (P06241) | Biotech Hunter | Biotech Hunter